selenocysteine has been researched along with Lung Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Guo, J; Ma, K; Ma, Q; Sun, S; Xu, J; Xu, W; Yang, R; Yang, Y; Zhang, J; Zhang, Y | 1 |
Guo, D; Huang, J; Ji, X; Li, J; Liu, C; Ma, J; Song, H; Sun, J; Zhang, J; Zhou, Y | 1 |
Chung, AS; Jung, JY; Kim, A; Lee, SH; Lim, JS; Son, M | 1 |
Inagaki, K; Sakaguchi, H; Stadtman, TC; Takahata, M; Tamura, T; Tanaka, H; Yamamoto, S | 1 |
El-Sayed, WM; Franklin, MR; Li, L; Roberts, JC; Szakacs, JG; Xie, Y | 1 |
Liu, SY; Stadtman, TC | 1 |
6 other study(ies) available for selenocysteine and Lung Neoplasms
Article | Year |
---|---|
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Glucose Transporter Type 1; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Naphthoquinones; NF-E2-Related Factor 2; Pyrazoles; Quinolines; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin Reductase 1 | 2022 |
L-Se-methylselenocysteine sensitizes lung carcinoma to chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Female; Humans; Hydrogels; Lipid Peroxidation; Lung Neoplasms; Mice; Mice, Nude; Reactive Oxygen Species; Selenocysteine; Xenograft Model Antitumor Assays | 2021 |
Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
Topics: Animals; Cell Adhesion; Cell Movement; Cell Survival; Cysteine; Dietary Supplements; Female; Fibronectins; Flow Cytometry; Gelatinases; Humans; Integrin alphaVbeta3; Integrins; Lung Neoplasms; Melanoma, Experimental; Methanol; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Organoselenium Compounds; Selenocysteine; Sodium Selenite; Survival Rate; Tumor Cells, Cultured; Vitronectin; Wound Healing | 2008 |
Selenophosphate synthetase genes from lung adenocarcinoma cells: Sps1 for recycling L-selenocysteine and Sps2 for selenite assimilation.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Base Sequence; Cell Line, Tumor; Escherichia coli; Genetic Complementation Test; Humans; Lung Neoplasms; Models, Biological; Molecular Sequence Data; Oncogenes; Phosphotransferases; Phylogeny; Plasmids; Recombinant Proteins; Selenocysteine; Sequence Homology, Amino Acid; Sodium Selenite | 2004 |
Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse.
Topics: Animals; Body Weight; Carcinogens; Female; Glutathione Peroxidase; Liver; Lung Neoplasms; Mice; Nicotiana; Nitrosamines; Organ Size; Prodrugs; Selenium; Selenocysteine | 2005 |
Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Amino Acid Sequence; Base Sequence; Binding Sites; Chromatography, Affinity; Chromatography, Gel; Chromatography, High Pressure Liquid; Dithionitrobenzoic Acid; Electrophoresis, Polyacrylamide Gel; Flavin-Adenine Dinucleotide; HeLa Cells; Heparin; Humans; Kinetics; Lung Neoplasms; Peptide Fragments; Placenta; Selenium; Selenocysteine; Thioredoxin-Disulfide Reductase; Tumor Cells, Cultured | 1997 |